Preterm Feeding Maturity Measurement and Evaluation

Informazioni relative al progetto

PREMADES

ID dell’accordo di sovvenzione: 651956

DOI

10.3030/651956

Progetto chiuso

Data della firma CE 30 Settembre 2014

Data di avvio 1 Ottobre 2014

Data di completamento 31 Marzo 2015

Finanziato da

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Costo totale

€ 71 429,00

Contributo UE

€ 50 000,00

Coordinato da

KUARTISMED MEDIKAL ARASTIRMA GELISTIRME DANISMANLIK EGITIM SANAYI VE TICARET LIMITED SIRKETI
Türkiye

Periodic Reporting for period 1 - PREMADES (Preterm Feeding Maturity Measurement and Evaluation)

Periodo di rendicontazione: 2014-10-01 al 2015-03-31

Sintesi del contesto e degli obiettivi generali del progetto

Synchronization of sucking, swallowing and breathing is vital for the feeding and hence well-being of newborns. Most of the term infants which born after the regular gestation period have coordinated sucking-swallowing patterns whereas these abilities are underdeveloped in preterm infants. The lack of development of effective feeding in premature infants can cause serious complications such as accidental deposits of food in the respiratory tract and the lungs, respiratory illnesses related problems like brain hypoxia, infections, respiratory arrest and even death. Further, this can also cause preterm infants get tired very quickly during feeding and thus impact their growth negatively. Our product detects and analyzes the feeding maturity of preterm infants in an objective manner, by analyzing the patterns captured from non-invasive sensors. During this action, a thorough analysis of our product and our business is completed. Furthermore, a detailed commercialization plan is set forth including also the operating plan. Finally, risk associated with different aspects of the business plan are assessed and contingency actions are determined.

Lavoro eseguito dall’inizio del progetto fino alla fine del periodo coperto dalla relazione e principali risultati finora ottenuti

A feasibility report including a business plan is prepared which elaborates the future commercialization efforts for our product.

Progressi oltre lo stato dell’arte e potenziale impatto previsto (incluso l’impatto socioeconomico e le implicazioni sociali più ampie del progetto fino ad ora)

Under the guidance of this feasibility report our company will continue to develop and commercialize our product. As commercialization efforts come to fruition, that is when our product started to be used by practitioners, not only an important problem for preterm infants will be diagnosed but also better clinical decisions will be made. Additionally, global health system will benefit from successful implementation of the business idea.

Logo of the company